Corneal Versus Conjunctival Delivery Using a Delivery Device

Effect Of Corneal Versus Conjunctival Delivery On The Corneal Safety, Tolerability, and Antihypertensive Efficacy Of The Xalatan Ophthalmic Delivery Device

Status

Withdrawn

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00143429

Enrollment

Registered

2005-09-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-Angle, Ocular Hypertension

Keywords

Primary Open Angle Glaucoma

Brief summary

Compare the antihypertensive efficacy of three methods for installing Xalatan

Interventions

DRUGXalatan

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of primary open angle glaucoma or ocular hypertension in 1 or both eyes

Exclusion criteria

* History of closed/barely open anterior chamber angle or a history of angle closure

Design outcomes

Primary

Measure	Time frame
IOP level in the study eye	—

Secondary

Measure	Time frame
Change in ocular safety assessments. Ocular and systemic adverse events throughout the study period	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026